Compliance & Validation — Documented
SOC 2 Type II, ISO 27001, 21 CFR Part 11
AI-first AuroraPrime platform for authoring clinical, regulatory, and safety documents with human-in-the-loop workflows.
AlphaLife Sciences, founded in 2020 with its U.S. headquarters in Iselin, New Jersey and offices in Singapore, provides AuroraPrime, an AI platform for authoring and quality-checking clinical, regulatory, and safety documents — including aggregate safety reports — with a human-in-the-loop model, and has announced a Veeva RIM integration and product partnership. The company states that it operates within 21 CFR Part 11, SOC 2 Type II, and ISO 27001 frameworks; confirm which claims are backed by current third-party audit reports versus self-assessed during evaluation.
64% — Partial coverage. Coverage score — how completely Atlas documents AlphaLife Sciences across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
SOC 2 Type II, ISO 27001, 21 CFR Part 11
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Pharmacovigilance, Regulatory Affairs, Medical Affairs
Natural Language Processing, Regulatory Submission Authoring
Private, Founded 2020
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?